Xiamen Comfort Science&Technology Group Co., Ltd
SZSE:002614.SZ
7.29 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 5,030.46 | 6,024.337 | 7,926.722 | 7,049.158 | 5,276.271 | 5,447.031 | 4,293.809 | 3,451.383 | 2,830.727 | 2,811.258 | 2,229.978 | 1,771.66 | 1,886.84 | 1,829.852 | 1,302.692 | 1,188.472 | 1,087.666 |
Cost of Revenue
| 3,165.557 | 4,082.535 | 5,559.473 | 4,631.354 | 3,312.686 | 3,472.211 | 2,705.274 | 2,216.748 | 1,890.656 | 1,906.173 | 1,743.231 | 1,471.676 | 1,527.732 | 1,470.649 | 1,044.167 | 984.913 | 881.94 |
Gross Profit
| 1,864.903 | 1,941.801 | 2,367.249 | 2,417.805 | 1,963.585 | 1,974.819 | 1,588.535 | 1,234.635 | 940.071 | 905.084 | 486.747 | 299.984 | 359.108 | 359.204 | 258.525 | 203.559 | 205.726 |
Gross Profit Ratio
| 0.371 | 0.322 | 0.299 | 0.343 | 0.372 | 0.363 | 0.37 | 0.358 | 0.332 | 0.322 | 0.218 | 0.169 | 0.19 | 0.196 | 0.198 | 0.171 | 0.189 |
Reseach & Development Expenses
| 218.548 | 246.655 | 289.42 | 268.785 | 226.869 | 183.433 | 10.619 | 12.536 | 19.883 | 17.099 | 11.682 | 11.026 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 99.181 | 99.317 | 142.503 | 112.771 | 108.346 | 104.207 | 100.774 | 81.221 | 66.17 | 69.651 | 40.497 | 39.135 | 153.698 | 122.776 | 83.757 | 77.249 | 67.384 |
Selling & Marketing Expenses
| 1,057.87 | 1,105.532 | 1,171.839 | 994.991 | 1,040.785 | 996.376 | 813.403 | 600.131 | 445.499 | 489.579 | 210.288 | 111.922 | 69.857 | 70.54 | 58.229 | 36.223 | 29.786 |
SG&A
| 1,157.05 | 1,204.849 | 1,314.341 | 1,107.762 | 1,149.13 | 1,100.583 | 914.176 | 681.352 | 511.669 | 559.23 | 250.785 | 151.057 | 223.555 | 193.316 | 141.986 | 113.473 | 97.17 |
Other Expenses
| -1.616 | 293.077 | 305.549 | 313.959 | 223.144 | -0.135 | -6.338 | 26.418 | 12.358 | -10.713 | 18.364 | 8.353 | 6.766 | 5.043 | 3.372 | 0.98 | 3.502 |
Operating Expenses
| 1,653.566 | 1,744.581 | 1,909.311 | 1,690.507 | 1,599.143 | 1,555.712 | 1,222.486 | 1,005.05 | 823.156 | 795.737 | 428.948 | 304.058 | 232.829 | 196.956 | 146.008 | 114.93 | 98.315 |
Operating Income
| 150.132 | 276.508 | 534.512 | 527.587 | 346.733 | 522.517 | 399.334 | 293.707 | 196.391 | 147.471 | 105.532 | 29.263 | 152.593 | 169.113 | 104.887 | 54.062 | 116.706 |
Operating Income Ratio
| 0.03 | 0.046 | 0.067 | 0.075 | 0.066 | 0.096 | 0.093 | 0.085 | 0.069 | 0.052 | 0.047 | 0.017 | 0.081 | 0.092 | 0.081 | 0.045 | 0.107 |
Total Other Income Expenses Net
| -57.834 | -108.808 | -6.908 | -10.266 | -1.119 | 105.087 | 37.367 | 80.568 | 90.885 | 54.34 | 64.118 | 40.5 | 32.94 | 11.908 | -4.258 | -33.587 | 12.798 |
Income Before Tax
| 153.504 | 167.7 | 527.605 | 517.321 | 345.614 | 524.194 | 403.416 | 310.153 | 207.8 | 163.688 | 121.918 | 36.425 | 159.219 | 174.155 | 108.259 | 55.042 | 120.208 |
Income Before Tax Ratio
| 0.031 | 0.028 | 0.067 | 0.073 | 0.066 | 0.096 | 0.094 | 0.09 | 0.073 | 0.058 | 0.055 | 0.021 | 0.084 | 0.095 | 0.083 | 0.046 | 0.111 |
Income Tax Expense
| 39.113 | 56.492 | 57.771 | 74.682 | 65.474 | 81.387 | 47.949 | 44.554 | 25.752 | 24.992 | 17.534 | 9.489 | 20.778 | 21.078 | 14.289 | 6.785 | 12.106 |
Net Income
| 103.203 | 102.023 | 458.358 | 439.276 | 288.978 | 439.122 | 345.18 | 251.03 | 180.554 | 140.218 | 104.347 | 27.391 | 138.441 | 153.077 | 93.97 | 46.024 | 88.175 |
Net Income Ratio
| 0.021 | 0.017 | 0.058 | 0.062 | 0.055 | 0.081 | 0.08 | 0.073 | 0.064 | 0.05 | 0.047 | 0.015 | 0.073 | 0.084 | 0.072 | 0.039 | 0.081 |
EPS
| 0.17 | 0.16 | 0.74 | 0.77 | 0.52 | 0.79 | 0.63 | 0.46 | 0.33 | 0.26 | 0.19 | 0.049 | 0.32 | 0.38 | 0.23 | 0.11 | 0.22 |
EPS Diluted
| 0.17 | 0.16 | 0.68 | 0.68 | 0.51 | 0.77 | 0.62 | 0.45 | 0.33 | 0.26 | 0.19 | 0.049 | 0.32 | 0.38 | 0.23 | 0.11 | 0.22 |
EBITDA
| 556.138 | 547.002 | 938.691 | 726.909 | 494.397 | 521.303 | 462.349 | 434.66 | 288.6 | 232.722 | 155.194 | 69.461 | 183.156 | 185.597 | 124.719 | 118.008 | 87.494 |
EBITDA Ratio
| 0.111 | 0.091 | 0.118 | 0.103 | 0.094 | 0.096 | 0.108 | 0.126 | 0.102 | 0.083 | 0.07 | 0.039 | 0.097 | 0.101 | 0.096 | 0.099 | 0.08 |